Has Basmah Abdalla, MD received payments from drug or device companies?

Yes. Drug and device makers reported $3,263 in general payments to Basmah Abdalla, MD across 13 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Basmah Abdalla, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Basmah Abdalla, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Basmah Abdalla, MD

Nephrology · Los Angeles, CANPI 1629394002

Payments from drug & device makers

$3,263in general payments, 2019–2025

Across 13 payments — averaging $250.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Mallinckrodt Enterprises LLC$2K
Sanofi-aventis U.S. LLC$491
Veloxis Pharmaceuticals, Inc.$167
AstraZeneca$130
Takeda Pharmaceuticals U.S.A., Inc.$125
Merck$64
plus $119 from 3 others

What the payments were for

Consulting fees$2,06063%
Speaking & faculty fees$35011%
Food & beverage$85326%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Mallinckrodt Enterprises LLC	3	$2,166
Sanofi-aventis U.S. LLC	2	$491
Veloxis Pharmaceuticals, Inc.	2	$167
AstraZeneca	1	$130
Takeda Pharmaceuticals U.S.A., Inc.	1	$125
Merck	1	$64
GSK	1	$60
Alnylam Pharmaceuticals Inc.	1	$35
Sanofi	1	$24

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,263 in reported general payments places this provider in the 65th percentile of 1,341 nephrology providers in California.

See all nephrology providers in California →

Medicare billing

Part B allowed, 2024

$116,478

Medicare patients

271

Services billed

1,001

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Atovaquone	36	$22,630
Cinacalcet Hcl	20	$10,982
Valganciclovir Hcl	24	$4,445
Fluconazole	28	$2,103
Tacrolimus	12	$1,886
Nifedipine ErNifedipine	28	$938
Prednisone	76	$673
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim	56	$339
Pantoprazole Sodium	49	$256
Carvedilol	43	$177
Losartan Potassium	22	$129
Amlodipine Besylate	18	$54
Furosemide	13	$35

Paid to pharmacies, not to this prescriber.

Other nephrology in Los Angeles

Anjay RastogiLos Angeles$6.3M
Mohamed El-ShahawyLos Angeles$4.4M
Suphamai BunnapradistLos Angeles$1.7M
Victor CarabelloLos Angeles$1.4M
John SimLos Angeles$1.3M
Tariq ShahLos Angeles$1.2M
Michael LevineLos Angeles$867K
Aamir JamalSan Dimas$5.5M
Kalpesh PatelCalabasas$3.6M
Jehad HaggiagiMission Hills$3.6M

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →